Literature DB >> 35067994

Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al.

G Avallone1, S Giordano1, C Astrua1, M Merli1, R Senetta2, C Conforti3, S Ribero1, A V Marzano4,5, P Quaglino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35067994     DOI： 10.1111/jdv.17959

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.

Authors:  F Falcinelli; A Lamberti; C Cota; P Rubegni; E Cinotti
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-04       Impact factor: 9.228

2.  Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?

Authors:  Nika Kianfar; Shayan Dasdar; Ali Salehi Farid; Kamran Balighi; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Front Med (Lausanne)       Date:  2022-07-19

Review 3.  Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.

Authors:  Carlo Alberto Maronese; Enrico Zelin; Gianluca Avallone; Chiara Moltrasio; Maurizio Romagnuolo; Simone Ribero; Pietro Quaglino; Angelo Valerio Marzano
Journal:  Front Med (Lausanne)       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.